Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

132 та иш

Иш: Detailed role of microRNA‐mediated regulation of PI3K/AKT axis in human tumors

  1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

    Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram +3

    Мақола201834 иқтибос
    ABI

  2. Breast Cancer Treatment

    Adrienne G. Waks, Eric P. Winer

    Шарҳ мақола201910 иқтибос
    ABI

  3. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

    Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit +6

    Мақола20147 иқтибос
    ABI

  4. Dysregulated microRNAs in colorectal carcinogenesis: New insight to cell survival and apoptosis regulation

    Alireza Anvarnia, Farzad Mohaddes‐Gharamaleki, Milad Asadi +3

    Шарҳ мақола20194 иқтибос
    ABI

  5. MicroRNA

    Thomas X. Lu, Marc E. Rothenberg

    Шарҳ мақола20174 иқтибос
    ABI

  6. The Role of mTOR Signaling as a Therapeutic Target in Cancer

    N. V. Popova, Manfred Jücker

    Шарҳ мақола20213 иқтибос
    ABI

  7. PI3K/Akt signalling pathway and cancer

    Juan Ángel Fresno Vara, E. Casado, Javier de Castro +3

    Шарҳ мақола20033 иқтибос
    ABI

  8. The blood–brain barrier and blood–tumour barrier in brain tumours and metastases

    Costas Arvanitis, Gino B. Ferraro, Rakesh K. Jain

    Шарҳ мақола20193 иқтибос
    ABI

  9. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma

    Farzad Rahmani, Aghigh Ziaeemehr, Soodabeh Shahidsales +6

    Шарҳ мақола20193 иқтибос
    ABI

  10. Screening and identification of epithelial-to-mesenchymal transition-related circRNA and miRNA in prostate cancer

    Zhijian Yan, Yiming Xiao, Yiyan Chen +1

    Мақола20193 иқтибос
    ABI

  11. Inhibition of MicroRNA miR-101-3p on prostate cancer progression by regulating Cullin 4B (CUL4B) and PI3K/AKT/mTOR signaling pathways

    Zhenhua Gu, Zhixin You, Yucheng Yang +4

    Мақола20212 иқтибос
    ABI

  12. let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells

    Fengyan Yu, Herui Yao, Pengcheng Zhu +8

    Мақола20072 иқтибос
    ABI

  13. PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects

    Rosalin Mishra, Hima Patel, Samar Alanazi +2

    Шарҳ мақола20212 иқтибос
    ABI

  14. Ovarian cancer

    Gordon C. Jayson, Elise C. Kohn, Henry C Kitchener +1

    Шарҳ мақола20142 иқтибос
    ABI

  15. Extracellular miRNA: A Collision of Two Paradigms

    Andrey Turchinovich, Alexander Tonevitsky, Barbara Burwinkel

    Шарҳ мақола20162 иқтибос
    ABI

  16. miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs

    Cheng‐Gong Liao, Ling‐Min Kong, Ping Zhou +4

    Мақола20142 иқтибос
    ABI

  17. PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges

    Mohammad Ahmed Khan, Vineet Jain, Md. Rizwanullah +2

    Шарҳ мақола20192 иқтибос
    ABI

  18. The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathway

    Lu Chen, Dongming Liu, Xianfu Yi +11

    Мақола20202 иқтибос
    ABI

  19. FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop

    Qinkai Zhang, Xunzhu Zhou, Maoping Wan +8

    Мақола20212 иқтибос
    ABI

  20. Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer

    Shuying He, Wen D. Song, Shudan Cui +4

    Мақола20232 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI